Edition:
India

Lupin Ltd (LUPN.BO)

LUPN.BO on Bombay Stock Exchange

1,461.50INR
11:29am IST
Change (% chg)

Rs-1.60 (-0.11%)
Prev Close
Rs1,463.10
Open
Rs1,465.00
Day's High
Rs1,470.00
Day's Low
Rs1,459.30
Volume
333,021
Avg. Vol
69,833
52-wk High
Rs1,750.00
52-wk Low
Rs1,294.05

LUPN.BO

Chart for LUPN.BO

About

Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central... (more)

Overall

Beta: -0.01
Market Cap(Mil.): Rs671,856.12
Shares Outstanding(Mil.): 451.58
Dividend: 7.50
Yield (%): 0.50

Financials

  LUPN.BO Industry Sector
P/E (TTM): 23.03 29.18 29.98
EPS (TTM): 64.61 -- --
ROI: -- 13.62 13.13
ROE: -- 14.52 14.27

BRIEF-Lupin Ltd gets FDA nod for generic Tobi inhalation solution

* Says lupin receives FDA approval for generic Tobi® inhalation solution

23 Mar 2017

BRIEF-Lupin Ltd launches generic Minastrin 24 Fe chewable tablets in U.S.

* Says Lupin launches generic Minastrin 24 Fe chewable tablets in the US

16 Mar 2017

BRIEF-Lupin launches its pain drug in the U.S.

* Says Lupin launches hydrocodone bitartrate and acetaminophen tablets in the U.S.

09 Mar 2017

BRIEF-Lupin launches generic drug to treat major depressive disorder

* Drug indicated to treat major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder Source text: http://bit.ly/2n9awVy Further company coverage:

07 Mar 2017

BRIEF-Lupin announces U.S. launch of generic drug to treat depression

* Says tablets are indicated for the treatment of major depressive disorder Source text: http://bit.ly/2mgR90c Further company coverage:

02 Mar 2017

BRIEF-Lupin launches product for scalp inflammation treatment in the U.S.

* Says Lupin launches generic Temovate® Clobetasol Propionate scalp application in the US

01 Mar 2017

BRIEF-Lupin receives USFDA approval for pain relievers

* Received final approval for its Oxycodone and Acetaminophen tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg from USFDA

28 Feb 2017

BRIEF-Lupin Ltd gets FDA nod for generic Suprep bowel prep kit

* Says Lupin receives FDA approval for generic Suprep bowel prep kit

28 Feb 2017

BRIEF-Lupin's unit Kyowa and Astellas enter into agreement

* Says Astellas and Lupin s subsidiary Kyowa enter into an agreement

27 Feb 2017

BRIEF-Lupin gets FDA nod for generic version of Bayer Healthcare's antibiotic drug

* Says gets final fda nod for moxifloxacin hydrochloride tablets Source text: http://bit.ly/2ksST6p Further company coverage:

16 Feb 2017

More From Around the Web

Earnings vs. Estimates